Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms-Reference-Cited by-同舟云学术

Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms

Published:2019 Issue:5 Volume:43 Page:700
ISSN:2233-6079
Container-title:Diabetes & Metabolism Journal
language:en
Short-container-title:Diabetes Metab J

Author:

Bellan Mattia¹²³^ORCID,Colletta Cosimo⁴^ORCID,Barbaglia Matteo Nazzareno¹,Salmi Livia¹,Clerici Roberto¹,Mallela Venkata Ramana¹,Castello Luigi Mario¹⁵,Saglietti Giuseppe⁶,Carnevale Schianca Gian Piero⁷,Minisini Rosalba¹,Pirisi Mario¹³⁷

Affiliation:

1. Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

2. Division of Internal Medicine, Sant'Andrea Hospital, Vercelli, Italy.

3. Interdisciplinary Research Center of Autoimmune Diseases (IRCAD), Novara, Italy.

4. COQ, Madonna del Popolo, Omegna, Italy.

5. Emergency Medicine Department, Maggiore della Carità Hospital, Novara, Italy.

6. Diabetes Clinic, ASL VCO, Verbania, Italy.

7. Division of Internal Medicine, AOU Maggiore della Carità Hospital, Novara, Italy.

Publisher

Korean Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.4093/dmj.2018.0201

Reference46 articles.

1. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals

2. Nonalcoholic fatty liver disease: Evolving paradigms

3. A Protein-TruncatingHSD17B13Variant and Protection from Chronic Liver Disease

4. NAFLD: A multisystem disease

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. miRNA and lncRNA as potential tissue biomarkers in hepatocellular carcinoma;Non-coding RNA Research;2024-03

2. Global prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus: an updated systematic review and meta-analysis;Gut;2023-07-25

3. Polymorphisms of HSD17B13, GCKR, HFE, and CP as factors of the development of non-alcoholic fatty liver disease and comorbid diseases;Meditsinskiy sovet = Medical Council;2023-05-25

4. Identification of shared genetic architecture between non-alcoholic fatty liver disease and type 2 diabetes: A genome-wide analysis;Frontiers in Endocrinology;2023-03-22

5. Review article: the role of HSD17B13 on global epidemiology, natural history, pathogenesis and treatment of NAFLD;Alimentary Pharmacology & Therapeutics;2022-11-09